Would you recommend an allogenic stem cell transplant in an older patient > 50 with Ph negative acute lymphoblastic leukemia who is MRD negative after induction?
Does your answer change based on clinical or molecular risk factors, and if so how?
Does your answer change if MRD status after induction is unknown?
Answer from: Medical Oncologist at Academic Institution
Assuming that the patient has standard-risk disease, there is no clear consensus regarding the optimal consolidation therapy for these patients. Consolidation chemotherapy produces 4-year survival rates of ~50%. If ALL achieves MRD-negativity early on, I generally recommend chemotherapy alone, espec...
Sign in or Register to read more